Annual Cash & Cash Equivalents
$12.06 M
+$6.78 M+128.63%
December 31, 2023
Summary
- As of February 8, 2025, ALIM annual cash & cash equivalents is $12.06 million, with the most recent change of +$6.78 million (+128.63%) on December 31, 2023.
- During the last 3 years, ALIM annual cash & cash equivalents has risen by +$850.00 thousand (+7.58%).
Performance
ALIM Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$10.83 M
-$3.49 M-24.35%
June 30, 2024
Summary
- As of February 8, 2025, ALIM quarterly cash and cash equivalents is $10.83 million, with the most recent change of -$3.49 million (-24.35%) on June 30, 2024.
- Over the past year, ALIM quarterly cash and cash equivalents has increased by +$2.54 million (+30.69%).
Performance
ALIM Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ALIM Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +128.6% | +30.7% |
| 3 y3 years | +7.6% | -56.3% |
| 5 y5 years | -7.5% | +37.0% |
ALIM Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -27.0% | -56.3% | -42.3% | -51.3% |
| 5 y | 5-year | -27.0% | -56.3% | -56.3% | -51.3% |
| alltime | all time | -84.3% | -59.7% | -85.9% | -55.1% |
Alimera Sciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $10.83 M(-24.4%) |
| Mar 2024 | - | $14.31 M(+18.7%) |
| Dec 2023 | $12.06 M(+128.6%) | $12.06 M(+45.5%) |
| Sep 2023 | - | $8.29 M(-55.9%) |
| Jun 2023 | - | $18.77 M(+43.5%) |
| Mar 2023 | - | $13.09 M(+148.1%) |
| Dec 2022 | $5.27 M(-68.1%) | $5.27 M(-4.4%) |
| Sep 2022 | - | $5.51 M(-29.8%) |
| Jun 2022 | - | $7.86 M(-21.0%) |
| Mar 2022 | - | $9.95 M(-39.8%) |
| Dec 2021 | $16.51 M(+47.3%) | $16.51 M(-23.3%) |
| Sep 2021 | - | $21.52 M(-13.1%) |
| Jun 2021 | - | $24.78 M(+199.8%) |
| Mar 2021 | - | $8.27 M(-26.2%) |
| Dec 2020 | $11.21 M(+18.9%) | $11.21 M(-0.4%) |
| Sep 2020 | - | $11.25 M(-16.6%) |
| Jun 2020 | - | $13.50 M(+10.2%) |
| Mar 2020 | - | $12.24 M(+29.9%) |
| Dec 2019 | $9.43 M(-27.7%) | $9.43 M(+19.3%) |
| Sep 2019 | - | $7.90 M(-35.0%) |
| Jun 2019 | - | $12.16 M(-7.2%) |
| Mar 2019 | - | $13.09 M(+0.4%) |
| Dec 2018 | $13.04 M(-45.8%) | $13.04 M(+3.6%) |
| Sep 2018 | - | $12.59 M(-24.5%) |
| Jun 2018 | - | $16.69 M(-17.6%) |
| Mar 2018 | - | $20.25 M(-15.8%) |
| Dec 2017 | $24.07 M(-22.3%) | $24.07 M(-6.1%) |
| Sep 2017 | - | $25.62 M(-4.7%) |
| Jun 2017 | - | $26.88 M(+0.5%) |
| Mar 2017 | - | $26.74 M(-13.7%) |
| Dec 2016 | $30.98 M | $30.98 M(-8.5%) |
| Sep 2016 | - | $33.85 M(+103.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2016 | - | $16.63 M(-30.5%) |
| Mar 2016 | - | $23.94 M(-23.0%) |
| Dec 2015 | $31.07 M(-59.5%) | $31.07 M(-21.0%) |
| Sep 2015 | - | $39.34 M(-18.3%) |
| Jun 2015 | - | $48.14 M(-21.5%) |
| Mar 2015 | - | $61.33 M(-20.0%) |
| Dec 2014 | $76.70 M(+507.4%) | $76.70 M(+24.9%) |
| Sep 2014 | - | $61.42 M(+46.3%) |
| Jun 2014 | - | $41.99 M(+1.6%) |
| Mar 2014 | - | $41.33 M(+227.3%) |
| Dec 2013 | $12.63 M(-74.5%) | $12.63 M(-45.3%) |
| Sep 2013 | - | $23.10 M(-27.6%) |
| Jun 2013 | - | $31.93 M(-18.8%) |
| Mar 2013 | - | $39.31 M(-20.7%) |
| Dec 2012 | $49.56 M(+49.7%) | $49.56 M(+185.6%) |
| Sep 2012 | - | $17.36 M(-22.1%) |
| Jun 2012 | - | $22.29 M(-19.3%) |
| Mar 2012 | - | $27.63 M(-16.6%) |
| Dec 2011 | $33.11 M(+16.1%) | $33.11 M(-13.1%) |
| Sep 2011 | - | $38.11 M(-13.3%) |
| Jun 2011 | - | $43.93 M(-11.2%) |
| Mar 2011 | - | $49.46 M(+73.4%) |
| Dec 2010 | $28.51 M(+486.9%) | $28.51 M(+93.8%) |
| Sep 2010 | - | $14.71 M(-67.8%) |
| Jun 2010 | - | $45.63 M(+221.9%) |
| Mar 2010 | - | $14.18 M(+191.8%) |
| Dec 2009 | $4.86 M(-72.8%) | $4.86 M(-50.9%) |
| Sep 2009 | - | $9.90 M(-44.6%) |
| Dec 2008 | $17.88 M(-14.3%) | $17.88 M(-42.3%) |
| Jun 2008 | - | $30.98 M(-6.3%) |
| Mar 2008 | - | $33.05 M |
| Dec 2007 | $20.85 M(-23.2%) | - |
| Dec 2006 | $27.16 M | - |
FAQ
- What is Alimera Sciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Alimera Sciences?
- What is Alimera Sciences annual cash & cash equivalents year-on-year change?
- What is Alimera Sciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Alimera Sciences?
- What is Alimera Sciences quarterly cash and cash equivalents year-on-year change?
What is Alimera Sciences annual cash & cash equivalents?
The current annual cash & cash equivalents of ALIM is $12.06 M
What is the all time high annual cash & cash equivalents for Alimera Sciences?
Alimera Sciences all-time high annual cash & cash equivalents is $76.70 M
What is Alimera Sciences annual cash & cash equivalents year-on-year change?
Over the past year, ALIM annual cash & cash equivalents has changed by +$6.78 M (+128.63%)
What is Alimera Sciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ALIM is $10.83 M
What is the all time high quarterly cash and cash equivalents for Alimera Sciences?
Alimera Sciences all-time high quarterly cash and cash equivalents is $76.70 M
What is Alimera Sciences quarterly cash and cash equivalents year-on-year change?
Over the past year, ALIM quarterly cash and cash equivalents has changed by +$2.54 M (+30.69%)